• HUMAN ISLETS FOR RESEARCH-We currently supply human islets to both the academic and corporate communities for their research related to diabetes. We pride ourselves on providing the highest quality islets, which we have been able to produce by using our proprietary media (PIM-Prodo Islet Media)

  • PRODO ISLET MEDIA (PIM)™- Our media is a cGMP product and has been designed to increase the viability and purity of the cells, from the initial recovery to the stage where the islets are ready for study and experiments. Our media is capable of long-term culturing, of up to 21 days, without loss of purity and viability.

  • OUR SERVICES-Prodo Labs is capable of performing many services on a contract basis. Some of these services include performing assays, animal isolations and islet testing.

  • RESEARCH-Working in conjunction with the Scharp-Lacy Research Institute, Prodo Labs is committed to performing research which could lead to a cure for diabetes. Led by Dr. David Scharp, MD, our company continues to break new ground in battling this debilitating disease.

Published Papers

Prodo Laboratories has had the following papers published:

-Islet Isolation From Human Pancreas With Extended Cold Ischemia Time: Published in July, 2010 by Transplant Proceedings.

The Article   |   Article Summary Data

Dr. David Scharp has published numerous papers over his career. If you are interested in reviewing any of these, please contact us.

Independent Researchers-Crediting Prodo Labs


-Improved Culture Medium Conditions For Human Islets-Released in July of 2011 by Division of Immunogenetics, Children’s Hospital of Pittsburgh, University of Pittsburgh, PA USA and Westminster College, New Wilmington, PA, USA (J. Zabo, S. Bertera, M. Trucco, R. Bottino)

View the poster here

Products

Prodo Labs provides high quality human islets for research as its primary service business by direct contracts with biotechnology and pharmaceutical companies utilizing them for in vitro and in vivo testing in the development of new drugs for diabetes or in the development of new insulin-producing cells for future transplants.

About Us

Prodo Laboratories, Inc was founded in Sept 2006 by David Scharp, MD to develop a biotechnology company that provides diabetes research services and products to both the academic and corporate diabetes research communities, as well as pursue its own research lines.